Oncology-Based Molecular Diagnostics Market Set to Reach USD 7.71 Billion by 2032
The oncology-based molecular diagnostics market is undergoing a transformative shift, propelled by technological innovation, increased awareness of early cancer detection, and the evolution of precision medicine. Valued at USD 2.76…